- Home
- KALA vs HHS Comparison
KALA vs HHS Comparison
Compare KALA & HHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- HHS
- Stock Information
- Founded
- KALA 2009
- HHS 1923
- Country
- KALA United States
- HHS United States
- Employees
- KALA N/A
- HHS N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- HHS Advertising
- Sector
- KALA Health Care
- HHS Consumer Discretionary
- Exchange
- KALA Nasdaq
- HHS Nasdaq
- Market Cap
- KALA 26.2M
- HHS 28.4M
- IPO Year
- KALA 2017
- HHS N/A
- Fundamental
- Price
- KALA $7.38
- HHS $3.44
- Analyst Decision
- KALA Strong Buy
- HHS
- Analyst Count
- KALA 3
- HHS 0
- Target Price
- KALA $14.00
- HHS N/A
- AVG Volume (30 Days)
- KALA 204.0K
- HHS 8.5K
- Earning Date
- KALA 08-05-2025
- HHS 08-07-2025
- Dividend Yield
- KALA N/A
- HHS N/A
- EPS Growth
- KALA N/A
- HHS N/A
- EPS
- KALA N/A
- HHS N/A
- Revenue
- KALA N/A
- HHS $181,355,000.00
- Revenue This Year
- KALA N/A
- HHS $6.54
- Revenue Next Year
- KALA N/A
- HHS N/A
- P/E Ratio
- KALA N/A
- HHS N/A
- Revenue Growth
- KALA N/A
- HHS N/A
- 52 Week Low
- KALA $2.92
- HHS $3.06
- 52 Week High
- KALA $11.20
- HHS $8.49
- Technical
- Relative Strength Index (RSI)
- KALA 74.24
- HHS 36.41
- Support Level
- KALA $5.35
- HHS $3.20
- Resistance Level
- KALA $8.49
- HHS $3.55
- Average True Range (ATR)
- KALA 0.79
- HHS 0.24
- MACD
- KALA 0.24
- HHS 0.01
- Stochastic Oscillator
- KALA 97.13
- HHS 23.71
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About HHS Harte-Hanks Inc.
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.